ERAS Competitors & Alternatives
Compare Erasca Inc with similar stocks in the same industry
Biotechnology
ERAS
Main Stock$10.27
Tradestie Score
49
Market Cap
$626.91M
Analyst Upside
+97.7%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.28
|
$3.40B | - | 54 | Compare |
|
QURE
uniQure N.V.
|
$24.93
|
$3.39B | - | 61 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$47.38
|
$3.33B | - | 58 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$34.14
|
$3.31B | - | 59 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$26.39
|
$3.09B | - | 58 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$28.69
|
$3.08B | - | 53 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$39.64
|
$3.03B | - | 56 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$53.71
|
$3.02B | - | 56 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$62.93
|
$3.01B | - | 52 | Compare |
More ERAS Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry